There is currently limited information regarding the prognostic ability of the dNLR-PNI (the combination of the derived neutrophil-to-lymphocyte ratio [dNLR] and prognostic nutritional index [PNI]) for hepatocellular carcinoma (HCC). | A novel combined systemic inflammationbased score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization